Clinical Trials Browser

Phase 1/2 × Urogenital Neoplasms × Androgen Antagonists × Clear all

NCT05067140 2025-03-17

A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer

Phase 1/2 Active not recruiting

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms